Patents by Inventor VERONIQUE SEMJONOW

VERONIQUE SEMJONOW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC METHOD EMPLOYING HNL
    Publication number: 20220165372
    Abstract: The present invention relates to the means and methods for the detection of bacterial infections, methods discriminating between viral and bacterial infections, methods of stratifying patients for subsequent treatment and further diagnostic purposes and methods to monitor antibiotherapy. The present invention is based on the detection of specific epitopes of human neutrophil lipocalin (HNL) using specific binding agents.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 26, 2022
    Inventors: MARKUS HENDRIKUS VAN ROOSMALEN, VERONIQUE SEMJONOW, JEROEN HANS NIEUWENHUIS, PER VENGE
  • Diagnostic method employing HNL
    Patent number: 11270782
    Abstract: The present invention relates to the means and methods for the detection of bacterial infections, methods discriminating between viral and bacterial infections, methods of stratifying patients for subsequent treatment and further diagnostic purposes and methods to monitor antibiotherapy. The present invention is based on the detection of specific epitopes of human neutrophil lipocalin (HNL) using specific binding agents.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: March 8, 2022
    Assignee: Koninklijke Philips N.V.
    Inventors: Markus Hendrikus Van Roosmalen, Veronique Semjonow, Jeroen Hans Nieuwenhuis, Per Venge
  • DIAGNOSTIC METHOD EMPLOYING HNL
    Publication number: 20170356921
    Abstract: The present invention relates to the means and methods for the detection of bacterial infections, methods discriminating between viral and bacterial infections, methods of stratifying patients for subsequent treatment and further diagnostic purposes and methods to monitor antibiotherapy. The present invention is based on the detection of specific epitopes of human neutrophil lipocalin (HNL) using specific binding agents.
    Type: Application
    Filed: November 19, 2015
    Publication date: December 14, 2017
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: MARKUS HENDRIKUS VAN ROOSMALEN, VERONIQUE SEMJONOW, JEROEN HANS NIEUWENHUIS, PER VENGE